Logos Capital is a fundamental biotechnology-focused fund that seeks to combine in-house data analytics with scientific and clinical expertise to identify transformative therapies in healthcare.
85
Total Investments
77
Portfolio Companies
-
Exits
1
Industries
General Information
Industries
Biotechnology
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Logos Capital
Recent Investments (85)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Mar 2026 | |
| Series B | •••••• | Jan 2026 | |
| Series B | •••••• | Jan 2026 | |
| Series A | •••••• | Jan 2025 | |
| Series D | •••••• | Dec 2024 | |
•••• ••••
|
B | •••••• | Nov 2024 |
|
•••• ••••
|
Series C | •••••• | Jul 2024 |
|
•••• ••••
|
Post-IPO Equity | •••••• | Jun 2024 |
|
•••• ••••
|
Series C | •••••• | Apr 2024 |
|
•••• ••••
|
Post-IPO Equity | •••••• | Mar 2024 |
Latest News
Biyoteknoloji şirketi Expedition Therapeutics, 115 milyon dolar yatırım aldı
Webrazzi · Aug 06, 2026
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
